Rhythm Pharmaceuticals, Inc. (RYTM)
104.65
+2.45
(+2.40%)
USD |
NASDAQ |
Sep 11, 16:00
104.65
0.00 (0.00%)
After-Hours: 17:09
Rhythm Pharmaceuticals Gross Profit (TTM) : 213.32M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 213.32M |
| March 31, 2026 | 193.83M |
| December 31, 2025 | 169.81M |
| September 30, 2025 | 155.24M |
| June 30, 2025 | 138.79M |
| March 31, 2025 | 121.97M |
| December 31, 2024 | 116.05M |
| September 30, 2024 | 98.97M |
| June 30, 2024 | 89.58M |
| March 31, 2024 | 80.39M |
| December 31, 2023 | 67.22M |
| September 30, 2023 | 53.96M |
| June 30, 2023 | 37.66M |
| March 31, 2023 | 29.36M |
| December 31, 2022 | 20.61M |
| September 30, 2022 | 14.44M |
| June 30, 2022 | 11.49M |
| March 31, 2022 | 2.957M |
| December 31, 2021 | 1.739M |
| September 30, 2021 | 0.191M |
| June 30, 2021 | -0.586M |
| March 31, 2021 | -0.693M |
| December 31, 2020 | -0.69M |
| September 30, 2020 | -0.703M |
| June 30, 2020 | -0.722M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.756M |
| December 31, 2019 | -0.834M |
| September 30, 2019 | -0.857M |
| June 30, 2019 | -0.772M |
| March 31, 2019 | -0.626M |
| December 31, 2018 | -0.442M |
| September 30, 2018 | -0.288M |
| June 30, 2018 | -0.237M |
| March 31, 2018 | -0.23M |
| December 31, 2017 | -0.223M |
| September 30, 2017 | -0.219M |
| June 30, 2017 | -0.197M |
| March 31, 2017 | -0.143M |
| September 30, 2016 | -0.089M |
| June 30, 2016 | -0.033M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| BioMarin Pharmaceutical, Inc. | 2.556B |
| Cytokinetics, Inc. | 46.98M |
| Exelixis, Inc. | 2.350B |